Lower starting dose of afatinib for the treatment of metastatic lung adenocarcinoma harboring exon 21 and exon 19 mutations

Overview of attention for article published in BMC Cancer, May 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 940 followers.

Lower starting dose of afatinib for the treatment of metastatic lung adenocarcinoma harboring exon 21 and exon 19 mutations https://t.co/WNk5aFfN1R

New article: Lower starting dose of afatinib for the treatment of metastatic lung adenocarcinoma harboring exon 21 and exon 19 mutations https://t.co/fVRFFN2vlB #lungcancer #oncology https://t.co/cb14Iw7Se1

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.